Ralph B. Sr. D’agostino

Ralph B. Sr. D’agostino's AcademicInfluence.com Rankings

Mathematics

#2025

World Rank

#3193

Historical Rank

Statistics

#69

World Rank

#96

Historical Rank

Measure Theory

#76

World Rank

#126

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Ralph B. Sr. D’agostino Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ralph B. Sr. D’agostino's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prediction of coronary heart disease using risk factor categories. (1998) (9402)
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study (2008) (5834)
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. (1998) (4434)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) (3662)
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease (2002) (3071)
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. (1994) (3018)
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2736)
Goodness-of-Fit-Techniques (1987) (2551)
Vitamin D Deficiency and Risk of Cardiovascular Disease (2008) (2511)
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study (2007) (2465)
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. (2001) (2147)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers (2011) (2069)
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study (2004) (1988)
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. (2002) (1898)
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus (2005) (1885)
A controlled trial of renal denervation for resistant hypertension. (2014) (1851)
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. (1997) (1767)
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study (2003) (1754)
Probability of stroke: a risk profile from the Framingham Study. (1991) (1743)
A Suggestion for Using Powerful and Informative Tests of Normality (1990) (1623)
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (2004) (1595)
Fibrinogen and risk of cardiovascular disease. The Framingham Study. (1987) (1588)
Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study (2002) (1517)
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. (2002) (1499)
The prevention and treatment of missing data in clinical trials. (2012) (1495)
Stent thrombosis in randomized clinical trials of drug-eluting stents. (2007) (1484)
Multiple biomarkers for the prediction of first major cardiovascular events and death. (2006) (1347)
Stroke severity in atrial fibrillation. The Framingham Study. (1996) (1320)
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation (2004) (1320)
National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making (1988) (1286)
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. (1995) (1227)
Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age (2006) (1216)
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. (1994) (1195)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (2005) (1195)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
One-year cardiovascular event rates in outpatients with atherothrombosis. (2007) (987)
Left atrial size and the risk of stroke and death. The Framingham Heart Study. (1995) (962)
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. (2006) (958)
C-reactive protein, fibrinogen, and cardiovascular disease prediction. (2012) (952)
On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data (2011) (937)
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study (2009) (932)
Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community (2007) (916)
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. (2007) (891)
Cigarette smoking as a risk factor for stroke. The Framingham Study. (1988) (862)
Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study (2001) (843)
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. (2007) (797)
Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study (2009) (797)
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. (1990) (769)
Stenting and medical therapy for atherosclerotic renal-artery stenosis. (2014) (764)
Genotype score in addition to common risk factors for prediction of type 2 diabetes. (2008) (761)
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. (2007) (756)
Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study (2005) (745)
Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. (2004) (740)
Clustering of metabolic factors and coronary heart disease. (1999) (730)
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. (2000) (727)
Presentation of multivariate data for clinical use: The Framingham Study risk score functions (2004) (717)
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. (2005) (712)
Carotid-wall intima-media thickness and cardiovascular events. (2011) (710)
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. (2001) (704)
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study (2003) (703)
Impact of atrial fibrillation on mortality, stroke, and medical costs. (1998) (703)
The influence of gender and age on disability following ischemic stroke: the Framingham study. (2003) (684)
Intermittent claudication. A risk profile from The Framingham Heart Study. (1997) (681)
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study (2003) (680)
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. (1994) (677)
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study (2004) (675)
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. (1993) (660)
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. (1994) (642)
Variability of body weight and health outcomes in the Framingham population. (1991) (632)
Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics (2002) (631)
Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. (2004) (631)
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. (2010) (626)
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. (2007) (621)
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. (2001) (618)
Tests for departure from normality. Empirical results for the distributions of b2 and √b1 (1973) (612)
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. (1984) (608)
Primary and subsequent coronary risk appraisal: new results from the Framingham study. (2000) (592)
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. (2003) (591)
Influence of heart rate on mortality among persons with hypertension: the Framingham Study. (1993) (584)
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. (2004) (572)
Obesity and the risk of new-onset atrial fibrillation. (2004) (566)
Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005 (2009) (563)
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study (2007) (556)
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. (2000) (554)
Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study (1997) (543)
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study (1992) (541)
Association of Cardiometabolic Multimorbidity With Mortality. (2015) (535)
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. (2002) (530)
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. (1987) (529)
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls (2005) (518)
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study (2007) (511)
Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence (2005) (502)
The randomized registry trial--the next disruptive technology in clinical research? (2013) (501)
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. (2003) (500)
Incidence of dementia and probable Alzheimer's disease in a general population (1993) (494)
An omnibus test of normality for moderate and large size samples (1971) (493)
Application of new cholesterol guidelines to a population-based sample. (2014) (486)
Framingham risk score and prediction of lifetime risk for coronary heart disease. (2004) (483)
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. (1995) (471)
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. (1990) (469)
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. (1996) (464)
Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. (1993) (463)
Propensity Scores in Cardiovascular Research (2007) (458)
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. (1993) (457)
Lipid-related markers and cardiovascular disease prediction. (2012) (457)
Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study (2004) (452)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction (2008) (443)
Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries (2020) (433)
Sudden coronary death in women. (1998) (414)
Profile for estimating risk of heart failure. (1999) (410)
Interpreting incremental value of markers added to risk prediction models. (2012) (408)
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. (2003) (395)
Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. (1990) (394)
Transformation to normality of the null distribution of g1 (1970) (393)
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. (2015) (388)
Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study (2006) (386)
Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality: The Framingham Heart Study (2003) (383)
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. (2007) (382)
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry (2009) (382)
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. (2010) (378)
Lifetime risk of dementia and Alzheimer's disease (1997) (377)
Trends in cardiovascular complications of diabetes. (2004) (377)
Mitral annular calcification and the risk of stroke in an elderly cohort. (1992) (375)
NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study (1997) (365)
Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. (2006) (365)
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas (2003) (364)
Effect of Aging on A1C Levels in Individuals Without Diabetes (2008) (360)
The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. (1987) (358)
Secular Trends in Stroke Incidence and Mortality: The Framingham Study (1992) (355)
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. (2001) (351)
Precursors of extracranial carotid atherosclerosis in the Framingham Study (1994) (350)
Obesity, diabetes and cognitive deficit: The Framingham Heart Study (2005) (345)
Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures (2003) (341)
Pulse pressure and risk of new-onset atrial fibrillation. (2007) (339)
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study (2006) (338)
Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. (1999) (337)
Estimating treatment effects using observational data. (2007) (332)
Estimating treatment effects using observational data. (2007) (332)
Reply: 2013 ACC/AHA guideline on the assessment of cardiovascular risk. (2014) (331)
A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study (2007) (331)
Blood Pressure as a Risk Factor for Cardiovascular Disease The Framingham Study—30 Years of Follow‐up (1989) (326)
Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population (2000) (326)
Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study (2005) (312)
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. (2008) (310)
Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. (1997) (310)
Statistical methods for assessment of added usefulness of new biomarkers (2010) (307)
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. (2007) (303)
Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. (2005) (301)
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study (2008) (298)
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. (1999) (297)
High-density lipoproteins: a consensus statement from the National Lipid Association. (2013) (293)
Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. (2003) (293)
Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. (2004) (287)
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. (2003) (287)
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. (2006) (287)
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. (2007) (285)
Number of pregnancies and the subsequent risk of cardiovascular disease. (1993) (283)
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study (2009) (280)
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. (2004) (279)
Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease (2015) (279)
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. (2012) (279)
Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. (2004) (278)
Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. (2008) (277)
Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. (2008) (276)
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. (1999) (274)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. (1996) (274)
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. (2008) (271)
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. (2011) (270)
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. (2001) (267)
A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study (2008) (267)
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study (2008) (267)
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. (1988) (264)
Evaluating Discrimination of Risk Prediction Models: The C Statistic. (2015) (263)
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? (1993) (260)
Tests for departure from normality: Comparison of powers (1977) (260)
Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study (2003) (258)
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study (2002) (258)
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. (2005) (257)
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. (2005) (255)
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models (2012) (254)
Resistin, adiponectin, and risk of heart failure the Framingham offspring study. (2009) (252)
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. (2008) (251)
Aortic calcified plaques and cardiovascular disease (the Framingham Study). (1990) (249)
Marital Status, Marital Strain, and Risk of Coronary Heart Disease or Total Mortality: The Framingham Offspring Study (2007) (244)
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. (2013) (242)
Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression (2005) (242)
Temporal patterns of stroke onset. The Framingham Study. (1995) (241)
Framingham Stroke Risk Profile and Lowered Cognitive Performance (2004) (234)
Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. (1991) (231)
Pericardial Fat, Intrathoracic Fat, and Measures of Left Ventricular Structure and Function: The Framingham Heart Study (2009) (230)
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. (1996) (228)
Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future? (2010) (228)
Stroke risk profile, brain volume, and cognitive function (2004) (227)
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports (2007) (227)
Genetic and non-genetic correlates of vitamins K and D (2009) (225)
The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. (1980) (225)
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. (2016) (222)
Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men (2006) (222)
Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study (2004) (221)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
Cardiovascular Disease Risk Assessment: Insights from Framingham. (2013) (216)
A Genetic Risk Score Is Associated With Incident Cardiovascular Disease and Coronary Artery Calcium: The Framingham Heart Study (2012) (216)
Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors (2005) (215)
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque (2011) (214)
Tests for Departure from Normality (1973) (214)
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. (2012) (214)
The Appropriateness of Some Common Procedures for Testing the Equality of Two Independent Binomial Populations (1988) (213)
Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects (2002) (209)
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. (1992) (207)
Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. (1996) (207)
Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study (2007) (206)
Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study (2007) (204)
Association between obesity and a prothrombotic state: the Framingham Offspring Study (2004) (203)
Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study (2008) (201)
Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. (1997) (201)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. (2000) (200)
Prehospital advanced life support: benefits in trauma. (1984) (199)
Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes (2007) (199)
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. (2006) (199)
Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study. (2004) (195)
Misuse of DeLong test to compare AUCs for nested models (2012) (194)
Effect of weight on cardiovascular disease. (1997) (192)
The health risks of smoking. The Framingham Study: 34 years of follow-up. (1993) (191)
New Guidelines for Statistical Reporting in the Journal. (2019) (191)
Effect of Aging on A1C Levels in Persons without Diabetes: Evidence from the Framingham Offspring Study and NHANES 2001-2004 (2008) (191)
Dietary lipid predictors of coronary heart disease in men. The Framingham Study. (1991) (190)
Glycated hemoglobin measurement and prediction of cardiovascular disease. (2014) (189)
Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. (1986) (188)
Social networks and inflammatory markers in the Framingham Heart Study. (2006) (188)
Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. (2006) (188)
Increasing trends in incidence of overweight and obesity over 5 decades. (2007) (187)
Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. (1989) (187)
Sexual Killers and Their Victims (1986) (186)
Sudden death risk in overt coronary heart disease: the Framingham Study. (1987) (186)
Challenges in the Design and Interpretation of Noninferiority Trials (2017) (185)
Robustness of the two independent samples t-test when applied to ordinal scaled data. (1987) (185)
Longitudinal threshold changes in older men with audiometric notches (2000) (184)
Alcohol consumption and cognitive performance in the Framingham Heart Study. (1999) (184)
Anger and Hostility Predict the Development of Atrial Fibrillation in Men in the Framingham Offspring Study (2004) (183)
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. (2014) (182)
An international model to predict recurrent cardiovascular disease. (2012) (181)
C-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women: The Framingham Heart Study (2002) (180)
Accuracy of Offspring Reports of Parental Cardiovascular Disease History: The Framingham Offspring Study (2004) (179)
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study (2007) (179)
Determinants of isolated systolic hypertension. (1988) (178)
Association of blood pressure with fibrinolytic potential in the Framingham offspring population. (2000) (178)
Alcohol Consumption and Risk of Ischemic Stroke: The Framingham Study (2002) (177)
Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. (2008) (177)
Tension and Anxiety and the Prediction of the 10-Year Incidence of Coronary Heart Disease, Atrial Fibrillation, and Total Mortality: The Framingham Offspring Study (2005) (176)
Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality. (2015) (175)
Job strain and health-related quality of life in a national sample. (1994) (175)
Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. (1996) (174)
Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms (2010) (171)
Association of parental heart failure with risk of heart failure in offspring. (2006) (169)
Predictors of smoking cessation: the Framingham Study. (1992) (169)
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. (2000) (168)
Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. (1995) (168)
Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. (2003) (168)
Dietary patterns predict the development of overweight in women: The Framingham Nutrition Studies. (2002) (168)
Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome (2014) (168)
Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. (2002) (166)
Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. (2006) (166)
Concept and usefulness of cardiovascular risk profiles. (2004) (166)
Central auditory dysfunction, cognitive dysfunction, and dementia in older people. (1996) (165)
Functional limitations and disability among elders in the Framingham Study. (1992) (164)
Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. (2001) (162)
Choice of time scale and its effect on significance of predictors in longitudinal studies (2007) (161)
Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop (2001) (161)
Intellectual decline after stroke: the Framingham Study. (1998) (158)
Serum Cholesterol and Cognitive Performance in the Framingham Heart Study (2005) (158)
Estimated Risks for Developing Obesity in the Framingham Heart Study (2005) (157)
Risk stratification of obesity as a coronary risk factor. (2002) (156)
Trajectories of Entering the Metabolic Syndrome: The Framingham Heart Study (2009) (156)
Body fat distribution and breast cancer in the Framingham Study. (1990) (156)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Leukocyte Telomere Length and Carotid Artery Intimal Medial Thickness: The Framingham Heart Study (2008) (155)
Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. (2001) (155)
Common Carotid Artery Intima-Media Thickness Progression as a Predictor of Stroke in Multi-Ethnic Study of Atherosclerosis (2011) (155)
A comparison of logistic regression to decision-tree induction in a medical domain. (1993) (155)
Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S] (2009) (152)
Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study (2016) (151)
Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. (1999) (151)
Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study (2002) (148)
Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. (2002) (147)
Benefits and Adverse Effects of Weight Loss: Observations from the Framingham Study (1993) (146)
Application of New Cholesterol Guidelines to a Population-Based Sample (2014) (144)
A likely explanation for the J-curve of blood pressure cardiovascular risk. (2004) (144)
Cardiovascular Risk Factors Predictive for Survival and Morbidity‐Free Survival in the Oldest‐Old Framingham Heart Study Participants (2005) (144)
Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. (2002) (144)
Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. (2015) (144)
Homocysteine and cognitive performance in the Framingham offspring study: age is important. (2005) (143)
Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. (1992) (142)
Lifetime risk of coronary heart disease by cholesterol levels at selected ages. (2003) (140)
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). (2007) (140)
Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection (2018) (139)
Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. (2003) (139)
A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. (2010) (139)
Physical activity and risk of breast cancer in the Framingham Heart Study. (1994) (138)
Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (2007) (137)
Tests for the Normal Distribution (2017) (135)
QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. (2005) (134)
Validation of an atrial fibrillation risk algorithm in whites and African Americans. (2010) (134)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement (2019) (132)
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. (1997) (131)
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community (2009) (131)
Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome (2018) (130)
Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups (2006) (130)
Development and testing of a new measure of case mix for use in office practice. (1995) (129)
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. (2010) (129)
Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (2004) (128)
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. (2012) (127)
External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. (2003) (126)
Associations of Carotid Artery Intima‐Media Thickness (IMT) With Risk Factors and Prevalent Cardiovascular Disease (2010) (124)
Plasma Homocysteine, Hypertension Incidence, and Blood Pressure Tracking: The Framingham Heart Study (2003) (123)
Effects of abdominal decompression on cardiopulmonary function and visceral perfusion in patients with intra-abdominal hypertension. (1998) (122)
Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. (2005) (122)
Validation of a dietary pattern approach for evaluating nutritional risk: the Framingham Nutrition Studies. (2001) (121)
Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study. (2001) (120)
Nonoperative management of adult blunt splenic injury with and without splenic artery embolotherapy: a meta-analysis. (2011) (119)
Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Cohort and Offspring Study (2004) (118)
Role of age, education, and gender on cognitive performance in the Framingham Heart Study: community-based norms. (1997) (118)
Physical activity and mortality in women in the Framingham Heart Study. (1994) (118)
Diet quality and obesity in women: the Framingham Nutrition Studies (2009) (117)
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome (2016) (117)
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis (2010) (117)
Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (2007) (116)
Psychosocial correlates of mammography screening in older African American women. (2007) (116)
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies (2016) (115)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
Impact of Atrial Fibrillation on the Risk of Death (1998) (115)
Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 (2020) (114)
Carotid Intima-Media Thickness Is Associated With Premature Parental Coronary Heart Disease: The Framingham Heart Study (2003) (112)
Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure: The Framingham Heart Study (2006) (111)
G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. (1998) (111)
Comparison of Techniques for Estimating Nutrient Intake: The Framingham Study (1992) (110)
The delayed-start study design. (2009) (109)
Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study (2016) (109)
New Norms for a New Generation: Cognitive Performance in the Framingham Offspring Cohort (2004) (108)
A comparison of performance of mathematical predictive methods for medical diagnosis: identifying acute cardiac ischemia among emergency department patients. (1995) (108)
Traditional multiplicity adjustment methods in clinical trials (2013) (108)
Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. (1995) (107)
Factors influencing survival and need for institutionalization following stroke: the Framingham Study. (1988) (107)
Time Course of Functional Recovery After Stroke: The Framingham Study (1989) (107)
Revised Framingham Stroke Risk Profile to Reflect Temporal Trends (2017) (107)
Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. (2005) (106)
Measuring effectiveness. What to expect without a randomized control group. (1995) (106)
Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. (2014) (105)
Hemostatic state and atrial fibrillation (the Framingham Offspring Study). (2001) (104)
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms (2010) (104)
Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues (2003) (104)
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. (2015) (104)
Alcohol Consumption and Hemostatic Factors: Analysis of the Framingham Offspring Cohort (2001) (104)
The internal validity of a dietary pattern analysis. The Framingham Nutrition Studies (2002) (104)
Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study (2008) (103)
C-reactive protein, inflammatory conditions, and cardiovascular disease risk. (2007) (103)
Changes in risk factors and the decline in mortality from cardiovascular disease. (1990) (103)
Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’ (2008) (102)
Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. (2004) (101)
Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study. (2005) (100)
Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. (2006) (100)
Does exercise reduce mortality rates in the elderly? Experience from the Framingham Heart Study. (1994) (99)
Association of educational level with inflammatory markers in the Framingham Offspring Study. (2006) (99)
Blood pressure, hypertension, and age as risk factors for poor cognitive performance. (1995) (99)
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. (2004) (99)
Update on fibrinogen as a cardiovascular risk factor. (1992) (98)
Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community (2010) (98)
Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life (2007) (98)
Mitral annular calcification is a predictor for incident atrial fibrillation. (2004) (95)
Blood pressure and cardiovascular morbidity and mortality rates in the elderly. (1997) (95)
Unique dietary patterns and chronic disease risk profiles of adult men: the Framingham nutrition studies. (2005) (95)
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study (2005) (94)
Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. (2002) (93)
Genetics of the Framingham Heart Study population. (2008) (93)
The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. (2005) (92)
Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration: The Framingham Heart Study (2007) (92)
Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? (2000) (91)
Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography (2017) (90)
Search for an optimal atherogenic lipid risk profile: from the Framingham Study. (2006) (90)
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. (2002) (89)
Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. (2003) (89)
Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study. (2001) (89)
Quantifying Importance of Major Risk Factors for Coronary Heart Disease (2018) (88)
Baldness and coronary heart disease rates in men from the Framingham Study. (1995) (88)
Patient-Specific Predictions of Outcomes in Myocardial Infarction for Real-Time Emergency Use: A Thrombolytic Predictive Instrument (1997) (88)
Dietary Patterns of Men and Women Suggest Targets for Health Promotion: The Framingham Nutrition Studies (1996) (86)
COVID-19 and climatic factors: A global analysis (2020) (86)
Changing end points in breast-cancer drug approval--the Avastin story. (2011) (86)
A randomized control trial of cardiac rehabilitation. (1987) (86)
[Coronary risk estimation in Spain using a calibrated Framingham function]. (2003) (85)
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study (2013) (85)
Risk Factor Profile and Management of Cerebrovascular Patients in the REACH Registry (2008) (84)
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). (2011) (84)
BMI vs. Waist Circumference for Identifying Vascular Risk (2008) (84)
Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. (1996) (84)
How do physicians adapt when the coronary care unit is full? A prospective multicenter study. (1987) (82)
Comparison of past versus recent physical activity in the prevention of premature death and coronary artery disease. (1999) (82)
Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. (2012) (82)
Cancer screening behaviors of low-income women: the impact of race. (1997) (80)
Does Hospitalization Impact Survival After Lower Respiratory Infection in Nursing Home Residents? (2004) (80)
Quantifying discrimination of Framingham risk functions with different survival C statistics (2012) (80)
Sex Hormone–Binding Globulin, but Not Testosterone, Is Associated Prospectively and Independently With Incident Metabolic Syndrome in Men (2011) (79)
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease (2017) (78)
Establishing the Link Between Lean Mass and Grip Strength Cut-points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. (2019) (77)
Survival and functional status 20 or more years after first stroke: the Framingham Study. (1998) (77)
Serum &ggr;-Glutamyl Transferase and Risk of Heart Failure in the Community (2010) (76)
Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). (2005) (76)
Key multiplicity issues in clinical drug development (2013) (76)
Wiley encyclopedia of clinical trials (2008) (76)
Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. (2002) (75)
Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study. (2016) (75)
Small Sample Probability Points for the D Test of Normality (1972) (74)
Risk estimation for recurrent Clostridium difficile infection based on clinical factors. (2014) (74)
Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. (2013) (74)
A SECOND LOOK AT ANALYSIS OF VARIANCE ON DICHOTOMOUS DATA (1971) (74)
Neck Circumference and the Development of Cardiovascular Disease Risk Factors in the Framingham Heart Study (2012) (74)
Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? (2009) (74)
Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Studys⃞ (2006) (73)
How Important is Functional Status as a Predictor of Service Use by Older People? (1990) (73)
Inference on Correlated Discrimination Measures in Survival Analysis: A Nonparametric Approach (2004) (72)
The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. (1994) (72)
Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. (2005) (71)
The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions (1997) (70)
Hypertension, Antihypertensive Treatment, and Sudden Coronary Death The Framingham Study (1988) (70)
Cost-effectiveness of statins. (1998) (69)
Platelet Glycoprotein IIIa PlA Polymorphism, Fibrinogen, and Platelet Aggregability: The Framingham Heart Study (2001) (69)
Clinical findings associated with radiographic pneumonia in nursing home residents. (2001) (68)
Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). (1992) (67)
Impact of heart rate and PR interval on Doppler indexes of left ventricular diastolic filling in an elderly cohort (the Framingham Heart Study). (1993) (67)
Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. (2012) (67)
Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study. (2001) (67)
Net reclassification index at event rate: properties and relationships (2017) (67)
Burden and Prognostic Importance of Subclinical Cardiovascular Disease in Overweight and Obese Individuals (2007) (67)
Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials (2003) (66)
Characteristics of Framingham offspring participants with long-lived parents. (2007) (65)
Multiplicity Considerations in Clinical Trials (2018) (65)
Age-adjusted survival curves with application in the Framingham Study. (1995) (65)
Left Ventricular Mass, Blood Pressure, and Lowered Cognitive Performance in the Framingham Offspring (2007) (65)
Heritability of the ankle-brachial index: the Framingham Offspring study. (2006) (65)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration (2019) (64)
Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. (2010) (64)
Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study (2015) (63)
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial (2017) (63)
The Role of Physicians in the Era of Predictive Analytics. (2015) (63)
Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. (2015) (62)
Predictors of mortality for lower respiratory infections in nursing home residents with dementia were validated transnationally. (2006) (62)
Effects of age on the distortion product otoacoustic emission growth functions (2002) (62)
Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. (2009) (61)
Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. (2000) (61)
Developing points‐based risk‐scoring systems in the presence of competing risks (2016) (61)
A risk score for chronic kidney disease in the general population. (2012) (61)
Secular trends in diet and risk factors for cardiovascular disease: the Framingham Study. (1995) (61)
Pharmaceutical Statistics Using SAS: A Practical Guide (2007) (60)
Association Between Increased Homocysteine Levels and Impaired Fibrinolytic Potential: Potential Mechanism for Cardiovascular Risk (2002) (59)
Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham heart study. (2008) (59)
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. (2014) (59)
Cross-sectional association of dietary patterns with insulin-resistant phenotypes among adults without diabetes in the Framingham Offspring Study (2009) (59)
Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. (2006) (58)
Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. (2008) (58)
Relations of inflammation and novel risk factors to valvular calcification. (2006) (58)
Simulation probability points of b2 for small samples (1971) (57)
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004) (57)
Best Paper of the 1980s:  National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐Making (2003) (57)
Aspirin intake and the use of serum ferritin as a measure of iron status. (2001) (57)
Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries (2010) (56)
Prediction Models - Development, Evaluation, and Clinical Application. (2020) (56)
Effects of Weather on Coronavirus Pandemic (2020) (56)
Sex‐Specific Differences in the Predictive Value of Cholesterol Homeostasis Markers and 10‐Year Cardiovascular Disease Event Rate in Framingham Offspring Study Participants (2013) (55)
Advance care planning and health care preferences of community-dwelling elders: the Framingham Heart Study. (2008) (55)
Management of risk factors. (1992) (54)
Use of Alternative Thresholds Defining Insulin Resistance to Predict Incident Type 2 Diabetes Mellitus and Cardiovascular Disease (2008) (54)
Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study. (2004) (54)
Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study). (2004) (54)
Associations of Adiponectin , Resistin , and Tumor Necrosis Factor-with Insulin Resistance (2008) (54)
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity (2008) (54)
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies (2009) (54)
Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham Nutrition Studies. (2004) (53)
Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome (2018) (53)
Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. (2007) (53)
Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study. (2014) (52)
Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
Debate: The slippery slope of surrogate outcomes (2000) (51)
Assessment of Genetic Determinants of the Association of &ggr;′ Fibrinogen in Relation to Cardiovascular Disease (2011) (51)
Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. (2010) (51)
Frailty models: Applications to biomedical and genetic studies (2011) (51)
Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective (2014) (50)
Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham Studies. (2003) (50)
Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction (2003) (50)
Contemporary trends in dyslipidemia in the Framingham Heart Study. (2009) (48)
Use of composite endpoints in clinical trials (2014) (48)
Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results. (1994) (47)
Temporal trends in the incidence of intermittent claudication from 1950 to 1999. (2005) (47)
Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel. (1999) (47)
Controlling alpha in a clinical trial: the case for secondary endpoints. (2000) (47)
Role of smoking in the U-shaped relation of cholesterol to mortality in men. The Framingham Study. (1995) (46)
Multiple comparisons in over-the-counter drug clinical trials with both positive and placebo controls. (1991) (45)
Alcohol consumption and risk of lung cancer: the Framingham Study. (2002) (45)
Maternal factors in onset of Huntington disease. (1985) (45)
Measures to assess the prognostic ability of the stratified Cox proportional hazards model (2009) (44)
Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking: Variations With Baseline Age, Body Mass Index, and Blood Pressure (2005) (44)
A Time‐Insensitive Predictive Instrument for Acute Hospital Mortality Due to Congestive Heart Failure: Development, Testing, and Use for Comparing Hospitals A Multicenter Study (1994) (43)
Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study (2016) (43)
Causes of late mortality with dual antiplatelet therapy after coronary stents. (2015) (43)
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model (2018) (43)
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. (2009) (42)
Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study (2011) (42)
Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. (2014) (42)
Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. (2011) (42)
Predictors of short-term functional decline in survivors of nursing home-acquired lower respiratory tract infection. (2003) (42)
Approaches to the null distribution of √ b1 (1973) (41)
Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials (2017) (41)
Secular trends in stroke in the Framingham Study. (1993) (40)
Genomewide linkage analysis of weight change in the Framingham Heart Study. (2005) (39)
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. (2015) (39)
Short-term menopausal hormone therapy for symptom relief: an updated decision model. (2004) (39)
Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database (2011) (39)
754-3 Impact of Atrial Fibrillation on the Risk of Death: The Framingham Study (1995) (39)
Trends in CHD and risk factors at age 55-64 in the Framingham Study. (1989) (39)
Alcohol consumption and the risk of bladder cancer in the Framingham Heart Study. (2004) (38)
Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study. (2016) (38)
Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension. (1993) (38)
Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study (2016) (38)
Is coronary-care-unit admission restricted for elderly patients? A multicenter study. (1991) (38)
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. (2008) (38)
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial). (2014) (38)
Long-term intraindividual cholesterol variability: natural course and adverse impact on morbidity and mortality--the Framingham Study. (1994) (37)
Discrimination slope and integrated discrimination improvement – properties, relationships and impact of calibration (2017) (37)
Ezetimibe and cancer--an uncertain association. (2008) (37)
Early-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study (2013) (37)
Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set). (2009) (36)
Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. (2008) (36)
Medical history for prognostic risk assessment and diagnosis of stable patients with suspected coronary artery disease. (2015) (35)
Common Genetic Variation in KCNH 2 Is Associated With QT Interval Duration The Framingham Heart Study (2007) (34)
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials (2013) (34)
Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study. (2002) (34)
Temporal Associations Between Smoking and Cardiovascular Disease, 1971 to 2006 (from the Framingham Heart Study). (2017) (34)
Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality (2011) (34)
Patterns of weight change and progression to overweight and obesity differ in men and women: implications for research and interventions (2012) (34)
Could the new England journal of medicine be biased against arthroscopic knee surgery? (2014) (34)
Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model (2018) (34)
Simple compact portable test of normality: Geary's test revisited. (1970) (34)
Randomized Pragmatic Trial of Stroke Transitional Care (2020) (33)
Physician electrocardiogram reading in the emergency department—Accuracy and effect on triage decisions (1992) (33)
Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study). (2005) (32)
Discrimination Index, the Area Under the ROC Curve (2002) (32)
Increased Platelet Aggregability Associated With Platelet GPIIIa PlA2 Polymorphism : The Framingham Offspring Study (1999) (31)
Understanding increments in model performance metrics (2013) (31)
Clinical correlates of hypertensive end-stage renal disease. (1998) (31)
A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study. (2003) (31)
Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes. (1996) (31)
Evaluating classification accuracy for modern learning approaches (2019) (30)
Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study. (1993) (30)
Does number of children increase the rate of coronary heart disease in men? (1995) (30)
A predictive instrument for acute ischemic heart disease to improve coronary care unit admission practices: a potential on-line tool in a computerized electrocardiograph. (1988) (30)
Dietary patterns of women are associated with incident abdominal obesity but not metabolic syndrome. (2012) (29)
Circulating Estrone Levels Are Associated Prospectively With Diabetes Risk in Men of the Framingham Heart Study (2013) (29)
Effect of Fludrocortisone Acetate on Chronic Unexplained Nausea and Abdominal Pain in Children With Orthostatic Intolerance (2014) (29)
Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study (2015) (29)
Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. (2012) (29)
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. (2007) (29)
Effectiveness of a Prehospital Medical Control System: An Analysis of the Interaction Between Emergency Room Physician and Paramedic (1981) (29)
Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women. (1996) (28)
Residential Proximity to Major Roads, Exposure to Fine Particulate Matter, and Coronary Artery Calcium: The Framingham Heart Study (2016) (28)
Application of net reclassification index to non-nested and point-based risk prediction models: a review. (2018) (28)
Antibiotic Treatment and Survival of Nursing Home Patients With Lower Respiratory Tract Infection: A Cross-National Analysis (2005) (28)
Widespread pain is a risk factor for cardiovascular mortality: results from the Framingham Heart Study. (2019) (28)
Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives (2014) (28)
Use of renin-angiotensin inhibitors in people with renal artery stenosis. (2014) (28)
The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta‐analysis * (1998) (28)
Linear Estimation of the Weibull Parameters (1971) (27)
Neck Circumference, Carotid Wall Intima-Media Thickness, and Incident Stroke (2013) (27)
The Importance of Cardiovascular Risk Factors in the Elderly. (1995) (27)
Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. (1996) (27)
Assessing the incremental predictive performance of novel biomarkers over standard predictors (2014) (27)
Diet, menopause, and serum cholesterol levels in women: the Framingham Study. (1993) (27)
An Obesity Dietary Quality Index Predicts Abdominal Obesity in Women: Potential Opportunity for New Prevention and Treatment Paradigms (2010) (26)
Concept of bridging the gap from youth to adulthood. (1995) (26)
The 27 Percent Rule Revisited (1975) (26)
Cervical cancer risk as a predictor of Pap smear use in rural North Carolina. (2002) (26)
Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence. (2016) (25)
Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study Published, JLR Papers in Press, April 1, 2005. DOI 10.1194/jlr.M400382-JLR200 (2005) (25)
Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control. (2009) (25)
Clinical decisions. The guidelines battle on starting statins. (2014) (25)
Developing points-based risk-scoring systems in the presence of competing risks. (2018) (25)
High plasma folate is negatively associated with leukocyte telomere length in Framingham Offspring cohort (2015) (25)
Relation between the Chi-Squared and ANOVA Tests for Testing the Equality of k Independent Dichotomous Populations (1972) (24)
Development of health risk appraisal functions in the presence of multiple indicators: the Framingham Study nursing home institutionalization model. (1995) (24)
Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (2002) (24)
External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction. (2018) (23)
Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community. (2014) (23)
Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population : Homocyst(e)ine, vitamins and arterial occlusive diseases (1996) (23)
The Mann–Whitney statistic: continuous use and discovery (2006) (22)
The Power of Geary's test of normality (1974) (22)
What to expect from net reclassification improvement with three categories (2014) (22)
Trends in the Association of Parental History of Obesity over 60 Years (2013) (22)
A Note on the Use of Confidence Limits following Rejection of a Null Hypothesis (1983) (22)
Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia—Its influence on diagnosis, triage, and short-term prognosis (1994) (22)
Norms for the mini-mental state examination. (1993) (21)
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial. (2016) (21)
Dietary predictors of serum cholesterol in men: the Framingham cohort population. (1992) (21)
An evidence-based score to detect prevalent peripheral artery disease (PAD) (2012) (21)
Circulating Sex Steroids and Vascular Calcification in Community-Dwelling Men: The Framingham Heart Study. (2016) (20)
Using survival methods to estimate age‐at‐onset distributions for genetic diseases with an application to Huntington disease (1989) (20)
Can We Trust Knee Meniscus Studies? One-Way Crossover Confounds Intent-to-Treat Statistical Methods. (2016) (20)
Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. (2011) (20)
Age and time need not and should not be eliminated from the coronary risk prediction models. (2005) (20)
Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment. (2012) (20)
Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality Autonomic Imbalance Predicts CVD, DM, Mortality. (2015) (20)
Radiomics of Coronary Artery Calcium in the Framingham Heart Study. (2020) (20)
Periodic Oscillations in Daily Reported Infections and Deaths for Coronavirus Disease 2019 (2020) (20)
Stability of the Framingham Nutritional Risk Score and its component nutrients over 8 years: The Framingham Nutrition Studies (2011) (19)
Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. (2005) (19)
Association of Parental Obesity with Concentrations of Select Systemic Biomarkers in Non-obese Offspring : The Framingham Heart Study (2008) (19)
Risk Factor Interaction in Cardiovascular and Cerebrovascular Disease (1987) (19)
Risk prediction and finding new independent prognostic factors. (2006) (19)
Impact of correlation on predictive ability of biomarkers (2013) (19)
EPIDEMIOLOGICAL BACKGROUND AND DESIGN : THE FRAMINGHAM STUDY (19)
Absence of Association Between Polymorphisms in the Hemostatic Factor Pathway Genes and Carotid Intimal Medial Thickness: The Framingham Heart Study (2004) (19)
Strategies for Dealing with Multiple Treatment Comparisons in Confirmatory Clinical Trials (1993) (19)
Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. (2019) (19)
Trends in All-Cause and Cardiovascular Disease Mortality among Women and Men with and without Diabetes in the Framingham Heart Study, 1950-2005 (2009) (19)
Global Two-Group Multiple Endpoint Adjustment Methods Applied to Clinical Trials (1999) (19)
Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study (2008) (19)
Relation of Risk Factors and Abdominal Aortic Calcium to Progression of Coronary Artery Calcium (from the Framingham Heart Study). (2017) (18)
Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. (2012) (18)
Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. (2004) (18)
Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study. (2017) (18)
The Contribution of Autonomic Imbalance to the Development of Metabolic Syndrome (2016) (18)
Decisive factors in the tolbutamide controversy. (1975) (17)
Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. (2013) (17)
Multiplicity Issues in Clinical Trials With Multiple Objectives (2013) (17)
Increased Aortic Diameters on Multidetector Computed Tomographic Scan Are Independent Predictors of Incident Adverse Cardiovascular Events: The Framingham Heart Study (2017) (16)
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis (2015) (16)
Single‐Molecule Counting of High‐Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study (2018) (16)
Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Superficial Femoral and Popliteal Artery Disease: 12-Month Results From the DANCE Clinical Trial. (2018) (16)
Optimal Identification of the Patient with Acute Myocardial Ischemia in the Emergency Room (1985) (16)
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study (2017) (16)
Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status. (1990) (16)
Emergency Medical Service Predictive Instrument–Aided Diagnosis and Treatment of Acute Coronary Syndromes and ST-segment Elevation Myocardial Infarction in the IMMEDIATE Trial (2011) (16)
New Developments in Medical Clinical Trials (2004) (15)
Research Pearls: The Significance of Statistics and Perils of Pooling. Part 2: Predictive Modeling. (2017) (15)
Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1‐year outcomes: A patient‐level analysis of randomized clinical trials (2017) (15)
Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events. (2016) (15)
Residential proximity to major roads, exposure to fine particulate matter and aortic calcium: the Framingham Heart Study, a cohort study (2017) (15)
Lifetime risk for developing dyslipidemia: the Framingham Offspring Study. (2007) (15)
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. (2003) (15)
Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U‐statistics (2017) (15)
Let's Not Put All Our Eggs in One Basket. (2015) (15)
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentary. (2008) (14)
Global risk assessment for cardiovascular disease and astute clinical judgement. (2003) (14)
A logistic regression model when some events precede treatment: the effect of thrombolytic therapy for acute myocardial infarction on the risk of cardiac arrest. (1997) (14)
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans (2018) (14)
Robustness of Location Estimators under Changes of Population Kurtosis (1977) (14)
Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis (2011) (14)
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post‐MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee (2018) (14)
Parental intermittent claudication as risk factor for claudication in adults. (2012) (13)
A Class of Simple Linear Estimators of the Standard Deviation of the Normal Distribution (1973) (13)
Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements. (2006) (13)
Quantifying cardiometabolic risk using modifiable non-self-reported risk factors. (2014) (13)
Linear Estimation of the Normal Distribution Standard Deviation (1970) (13)
Update on fibrinogen as a major cardiovascular risk factor: The framingham study (1990) (13)
Thoroughly Modern Risk Prediction? (2012) (13)
Relationship of Albuminuria and Renal Artery Stent OutcomesNovelty and Significance (2016) (13)
Carotid Intima-Media Thickness Is Associated With Premature Parental Coronary Heart Disease (2003) (13)
A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. (1992) (13)
Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. (2011) (13)
Epidemiology of Risk Factor Clustering in Elevated Blood Pressure (1998) (12)
Making genuine progress against metastatic breast cancer. (2012) (12)
Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. (2014) (12)
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community (2009) (12)
Impact of enzyme replacement therapy on survival in adults with Pompe disease (2013) (12)
Extension of adaptive alpha allocation methods for strong control of the family‐wise error rate (2013) (12)
Density and morphology of coronary artery calcium for the prediction of cardiovascular events: insights from the Framingham Heart Study (2019) (12)
Association of Parental Obesity With Concentrations of Select Systemic Biomarkers in Nonobese Offspring (2009) (12)
Performance of a method for identifying the unique dietary patterns of adult women and men: the Framingham nutrition studies. (2008) (12)
Colorectal cancer screening practices among low-income women (2000) (11)
Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia. (2016) (11)
Tutorials in Biostatistics: Statistical Modelling of Complex Medical Data (2005) (11)
Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance. (2012) (11)
Composite and multicomponent end points in clinical trials (2017) (11)
Evaluation of simethicone for the treatment of postoperative abdominal discomfort in infants. (1998) (11)
Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol (2011) (11)
Robustness and Power of Analysis of Covariance Applied to Data Distorted from Normality by Floor Effects: Non-Homogeneous Regression Slopes (2002) (11)
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis (2019) (11)
Beyond baseline data: the use of time-varying covariates. (2008) (10)
Corrections and Amendments: ‘Tests for departure from normality. Empirical results for the distributions of b2 and√b1’ (1974) (10)
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations (2021) (10)
The FDA and the Importance of Trust. (2020) (10)
Fucosyltransferase 3 polymorphism and atherothrombotic disease in the Framingham Offspring Study. (2007) (10)
Statistical inference for decision curve analysis, with applications to cataract diagnosis (2020) (10)
Abstract 4070: Increased CRP and Long Term Risk for Cardiovascular Events in Middle Age Men and Women (2006) (10)
The logistic function as an aid in the detection of acute coronary disease in emergency patients (a case study). (1982) (10)
Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease. (2019) (10)
Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice (2019) (10)
The Exclusion of Women from Clinical Trials of Thrombolytic Therapy (1995) (10)
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study (2017) (10)
Increased heart rate is associated with a prothrombotic state: The Framingham Heart Study (2017) (9)
Alcohol Consumption and Risk of Ischemic Stroke (2002) (9)
A modest proposal for a clinical trial on single-bundle versus double-bundle anterior cruciate ligament reconstruction. (2012) (9)
Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study. (2017) (9)
Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib (2018) (9)
Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. (2018) (9)
Test of normality against skewed alternatives. (1972) (9)
Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. (2001) (9)
Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration (2015) (9)
Blood kidney injury molecule–1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography—Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study (2019) (8)
Multiplicity adjustments in testing for bioequivalence (2015) (8)
Use of composite endpoints in clinical trials (2016) (8)
Surfactant-Replacement Therapy for Respiratory Distress Syndrome in the Preterm and Term Neonate: Congratulations and Corrections (2008) (8)
Tutorials in biostatistics (2013) (8)
Sensitivity and Specificity Can Change in Opposite Directions When New Predictive Markers Are Added to Risk Models (2014) (8)
Genome-wide linkage analyses and candidate gene fine mapping for HDL 3 cholesterol: the Framingham Study (2005) (8)
A Phase 3 Randomized, Historically-Controlled Clinical Trial Investigating the Use of Defibrotide in the Treatment of Severe Veno-Occlusive Disease Post-SCT: A Novel Approach to the Validation of a Promising New Drug for the Treatment of a Life Threatening Disease. (2007) (7)
Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community (2011) (7)
A systems analysis of age-related changes in some cardiac aging traits (2014) (7)
Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue (2018) (7)
Nonmenstrual toxic shock syndrome. Methodologic problems in estimating incidence and delineating risk factors. (1987) (7)
Abstract 1466: Obesity is Independently Associated With Long-term Risk of Cardiovascular Mortality and Underweight With Risk of Non-cardiovascular Mortality in Framingham Offspring Cohort (2009) (7)
Principal Components Analysis (2005) (7)
Surrogate markers: back to the future (2006) (7)
Multiple Endpoints, Multivariate Global Tests (2005) (6)
Quantifying Stroke Risk Factors and Potentials for Risk Reduction (1993) (6)
Guidelines American College of Cardiology/American Heart Association Task Force on Practice 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the (2013) (6)
Predicting new‐onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study (2018) (6)
A technique for summarizing longitudinal data (1993) (6)
A normal approximation for testing the equality of two independent Chi-square variables (1971) (6)
Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals (2018) (6)
Cluster Analysis, Variables (2005) (6)
On the Evaluation of the Kolmogorov Statistic (1973) (6)
Tutorials in Biostatistics: Statistical Methods in Clinical Studies (2005) (6)
Cardiac Nuclear Imaging: Adoption of an Evolving Technology (1984) (5)
Pubertal Progression in Female Adolescents with Progeria. (2017) (5)
Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution". (2012) (5)
Predictive performance of missing data methods for logistic regression, classification trees and neural networks (2001) (5)
Variability of body weight and health outcomes [2] (1991) (5)
Baseline 10-year cardiovascular risk scores predict cognitive function in older persons, and particularly women, living with HIV infection. (2020) (5)
PRIMARY AND READJUDICATION MORTALITY RESULTS FROM ZODIAC, A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA (2010) (5)
Coronary Artery Calcium Score–Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines (2020) (5)
Review of current advances in survival analysis and frailty models (2020) (5)
C-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women The Framingham Heart Study Brief Rapid Communications (2002) (5)
Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome. (2019) (5)
Editorial: Multiplicity issues in clinical trials (2017) (5)
Efficacy and tolerability of lovastatin in hypercholesterolemic women. (1992) (5)
The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women. (2000) (4)
Editorial Commentary: Meta-analyses Are on the Rise, but Are We Learning More? (2016) (4)
SAS macros for confidence interval estimation for CHD risk prediction by different survival models (2004) (4)
ENDOTHELIN-1 PREDICTS INCIDENT HEART FAILURE, INCIDENT MYOCARDIAL INFARCTION, CARDIOVASCULAR MORTALITY, AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING DIAGNOSTIC CORONARY ANGIOGRAPHY: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDY (2018) (4)
Risk of alzheimer disease is associated with parental age among apolipoprotein E ε4 heterozygotes (1997) (4)
Obesity and the Risk of New-Onset Atrial Fibrillation—Reply (2005) (4)
Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. (2015) (4)
Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients (2017) (4)
Departures from Normality, Tests for (2006) (4)
Discussion: Logical and analytical issues in dental/oral product comparison research (1992) (4)
Intellectual Decline Following Stroke: The Framingham Study (1987) (4)
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models (2019) (4)
Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients. (1992) (4)
Shoulder arthroscopy literature remains controversial. (2012) (4)
The Statistician and the Data Monitoring Committee (2004) (4)
Overview of missing data techniques. (2007) (4)
A technique for summarizing longitudinal data. (1993) (4)
Monocyte cytokine production, systemic inflammation and cardiovascular disease in very elderly men and women: The Framingham Heart Study (2004) (4)
MYOCARDIAL INFARCTION AFTER LATE DISCONTINUATION OF THIENOPYRIDINE THERAPY IN THE RANDOMIZED DAPT STUDY (2016) (4)
Statistical modelling of complex medical data (2004) (4)
Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals The Study Epidemiology (2005) (4)
Chronic Disease Data And Analysis: Current State Of the Field (2002) (4)
Stroke Risk Profile Predicts Brain Volume and Cognitive Function in Stroke-free Subjects: The Framingham Study (2001) (4)
Comments from the Editors (2008) (3)
Statistical methods in clinical studies (2004) (3)
Social indicators: A statistician's view (1975) (3)
Using observational data to estimate treatment effects. Authors' reply (2007) (3)
Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study. (2009) (3)
Editorial: quantifying the comparison of two groups. (1999) (3)
QUANTITATIVE IMPACT OF REMNANT LIPOPROTEINS ON RISK FOR HARD CHD EVENTS: A META-ANALYSIS OF THE FRAMINGHAM OFFSPRING AND JACKSON HEART STUDIES (2014) (3)
Authors' response to comments (2017) (3)
Longitudinal models for analysis of respiratory function. (1995) (3)
Obesity and the risk of new-onset atrial fibrillation. Author's reply (2005) (3)
Modeling Frailty as a Function of Observed Covariates (2007) (3)
Testing a Model That Evaluates Options for Rural Emergency Medical Service Development (1984) (3)
Linear Estimation of the Logistic Parameters for Complete or Tail-Censored Samples (1976) (3)
Abstract 1254: Development of a Risk Score for Incident Atrial Fibrillation in the Community; the Framingham Heart Study (2008) (3)
Algorithms for assessing cardiovascular risk in women. (2007) (3)
Pharmaceutical statistics using SA (2013) (2)
Abstract 14026: Remnant Lipoprotein Cholesterol Fractions and Risk for Cardiovascular Events in the Jackson Heart and Framingham Offspring Studies: A Meta-Analysis (2013) (2)
Glucose disposal rates and the glucose challenge in pregnant women. (1974) (2)
Chapter 3 Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN, and QRISK (2011) (2)
Increased mortality, stroke and medical costs imposed by atrial fibrillation (1996) (2)
Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium. (2018) (2)
With Atherothrombosis One-Year Cardiovascular Event Rates in Outpatients (2007) (2)
Inference of bioequivalence for log‐normal distributed data with unspecified variances (2014) (2)
Multivariate Bartlett Test (2005) (2)
An Analytic Method for the Evaluation of Rural Emergency Medical Service Development (1981) (2)
Multivariable Evaluation of Candidates for Cardiovascular Disease (2013) (2)
Plasma C-Reactive Protein, Systolic Hypertension and Risk of Ischemic Stroke and TIA: The Framingham Study (2001) (2)
Multiple Endpoints, Multivariate Global Tests† (2014) (2)
Factor Analysis, Second‐Order (2005) (2)
Surfactant Trials (2006) (2)
Clinical Correlates and Heritability of Vitamins K and D (2007) (2)
Factor Analysis, Confirmatory (2005) (2)
THE ZIPRASIDONE OBSERVATIONAL STUDY OF CARDIAC OUTCOMES (ZODIAC): FINDINGS FROM A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN REAL-WORLD USE AMONG 18154 PATIENTS WITH SCHIZOPHRENIA (2010) (2)
Microsimulation model to predict incremental value of biomarkers added to prognostic models (2018) (2)
Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups. (2023) (2)
COMPREHENSIVE ASSESSMENT OF TYPE 2 MYOCARDIAL INFARCTION IN AT-RISK PATIENTS: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDY (2016) (2)
QUANTITATIVE IMPACT OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND HDL SUBFRACTIONS ON RISK FOR HARD CHD EVENTS: A META-ANALYSIS OF THE FRAMINGHAM OFFSPRING AND JACKSON HEART STUDIES (2014) (2)
Circulating Estrogen Levels and Self-Reported Health and Mobility Limitation in Community-Dwelling Men of the Framingham Heart Study (2016) (2)
Case Illustration for Chapter 2: The FoCaS Project: Improving Breast and Cervical Cancer Screening among Low-Income Women (1999) (2)
Dietary patterns of women and men, apoe genotypes, and prevalence of the metabolic syndrome. The Framingham nutrition studies (2004) (2)
Metabolic Syndrome in Middle-Aged Adults in the Community Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Print (2007) (2)
Implications of Alternative Sampling Strategies for Emergency Medical Service Evaluation (1979) (2)
Statistics in Medicine moves into online submission (2004) (2)
Using Observational Data to Estimate Treatment Effects—Reply (2007) (1)
ietary Patterns , Smoking , and Subclinical eart Disease in Women : Opportunities for rimary Prevention from the Framingham utrition Studies (2004) (1)
Statistical Goodness-of-fit Techniques Applicable to Scintillation Data, (1980) (1)
No One Size Fits All: Scoring Risk of In-Hospital Death After Myocardial Infarction. (2016) (1)
Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration The Framingham Heart Study Genetics (2007) (1)
Abnormalities of cerebral white matter and stroke risk in the Framingham Offspring Study (2001) (1)
Abstract WP311: In-hospital Depression and Anxiety and History of Depression Predict 3 Months Post-stroke Depression and Anxiety (2016) (1)
Prothrombotic and reduced fibrinolytic state in association with homocysteinemia: the framingham offspring study (1998) (1)
Abstract 261: Relationship of Arginine Vasopressin and Blood Pressure in Patients with Orthostatic Intolerance and Nausea (2013) (1)
Technology Assessment in the Framingham Heart Study (1991) (1)
Abstract 1012: Added Value of the Common and Internal Carotid Intima-media Thickness (IMT) for the Prediction of Cardiovascular Events: The Framingham Offspring Study (2009) (1)
Long-term influence of fibrinogen on initial vs recurrent cardiovascular events: The framingham study (1996) (1)
Risk Prediction for Individuals--Reply. (2015) (1)
Abstract 14097: Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study (2013) (1)
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis. (2010) (1)
Commentary Debate: The slippery slope of surrogate outcomes (2000) (1)
Asymptotically Best Linear Unbiased Estimation of the Rayleigh Parameter for Complete and Tail-Censored Samples (1975) (1)
THRESHOLDS FOR ABDOMINAL AORTIC CALCIUM THAT PREDICT CARDIOVASCULAR DISEASE EVENTS IN THE FRAMINGHAM HEART STUDY (2016) (1)
Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease". (2015) (1)
Ambulatory blood pressure results of symplicity HTN-3 trial (2014) (1)
Pitavastatin 4 mg provides significantly greater reduction in remnant lipoprotein cholesterol compared to pravastatin 40 mg: Results from the prevail trial (2014) (1)
GUIDELINE-BASED STATIN ALLOCATION TO DISTINGUISH BOTH CARDIOVASCULAR EVENTS AND CORONARY ARTERY CALCIFICATION IN THE COMMUNITY: A COMPARISON OF THE 2004 NCEP ATP III AND 2013 ACC/AHA CHOLESTEROL TREATMENT GUIDELINE (2015) (1)
Single‐number summary and decision analytic measures can happily coexist (2019) (1)
Authors' reply (2012) (1)
Aspirin use and cardiovascular disease in women. (1992) (1)
Thresholds for Abdominal Aortic Calcium That Predict Cardiovascular Disease Events in the Framingham Heart Study. (2020) (1)
Association of γ’ Fibrinogen with Risk Factors and Prevalent Cardiovascular Disease in the Framingham Heart Study. (2007) (1)
Myocardial Infarction : The Framingham Heart Study Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without (2003) (1)
Abstract 1469: Neck Circumference and Development of Cardiovascular Disease Risk Factors in the Framingham Heart Study (2009) (1)
Abstract 13709: Incident Congestive Heart Failure and Common Carotid Artery Diameter: The Framingham Offspring Study (2011) (1)
A risk profile for stroke or death in atrial fibrillation: the Framingham heart study (2002) (1)
Biosimilar Clinical Development: Scientific Considerations and New Methodologies (2016) (1)
Differential Effects of Experience on House Officers' Admission Diagnoses for Patients with Possible Myocardial Infarction (1982) (1)
Factor Loading Matrix (2005) (1)
LONG-TERM RISK AND PROGNOSIS OF RECURRENT CARDIOVASCULAR EVENTS IN THE REACH REGISTRY (2012) (1)
Statistical Learning in Medical Research with Decision Threshold and Accuracy Evaluation (2021) (1)
Comment on Tests of Normality (1992) (1)
Issues of study design and data analysis. (1998) (1)
The future of clinical trials: A panel discussion (2012) (1)
Comparison of the power between the Mann Whitney and the Kolmogorov Smirnov Tests and the Chi Square and the Fisher Exact tests on discrete distributions (1964) (0)
Effects of Dietary Protein on Skeletal Muscle Mass and Sarcopenia Risk in Middle‐aged Framingham Adults (2015) (0)
Carbohydrate‐related dietary factors and plasma adiponectin levels in healthy adults in the Framingham Offspring Cohort. (2009) (0)
Abstract 18939: Impact of LDL Pattern on Risk for CHD in the Framingham Offspring Population (2012) (0)
A Clinical Trial Evaluation of Pager vs Smart-device Efficacy in an Academic Hospital Setting (2016) (0)
Abstract 11695: Development and Validation of New Cardiovascular Disease Risk Scores for Patients With Diabetes Mellitus From a Pooled Cohort of the US Population (2019) (0)
Plasma Homocysteine and Carotid Artery Intima‐Media Thickness: Site‐Specific Associations in the Framingham Offspring Cohort (2006) (0)
Abstract 20038: Maternal Pre-Pregnancy Overweight is Associated with Increased Cardiovascular Disease Mortality in the Framingham Heart Study (2014) (0)
Sex Specific Differences in the Predictive Value of Cholesterol Homeostasis Markers and 10‐Year CVD Event Rate in Framingham Offspring Study (2013) (0)
Prognostic/Clinical Prediction Models: Development of Health Risk Appraisal Functions in the Presence of Multiple Indicators: The Framingham Study Nursing Home Institutionalization Model (2005) (0)
Inference of Equivalence for the Ratio of Two Normal Means with Unspecified Variances (2014) (0)
Meta-Analysis Combining 2 Previously Reported Trials on Respiratory Distress Syndrome in Neonates: In Reply (2007) (0)
ross-Sectional Relations f Electrocardiographic QRS uration to Left Ventricular Dimensions he Framingham Heart Study (2016) (0)
28. A new fibrinogen immunoprecipitation test (FIPT) predicts prevalence of cardiovascular disease in the Framingham offspring population (1996) (0)
876-4 Physical inactivity and increased thrombolic risk: The Framingham heart study (2004) (0)
ONE SIZE DOES NOT FIT ALL: CONSIDERING DIFFERENT STATIN THERAPY CUTPOINTS BY AGE AND SEX (2015) (0)
Abstract 1037: Parental Occurrence of Intermittent Claudication is an Independent Risk Factor for Intermittent Claudication in Adult Offspring: The Framingham Heart Study (2009) (0)
Noninferiority Trials. (2018) (0)
FIRST Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes The IMMEDIATE Randomized Controlled Trial (2012) (0)
Multiple Endpoints, P Level Procedures† (2014) (0)
Diet and Physical Activity Dietary Quality Predicts Adult Weight Gain : Findings from the Framingham Offspring Study (2006) (0)
Improving cardiovascular risk assessment in British black and minority ethnic groups: recalibration of the Framingham risk-score (2005) (0)
Abstract 108: Women and Minorities Have Lower Patient-reported Functional Status 3 Months Post-stroke (2016) (0)
Covariate Effect on Constancy Assumption in Noninferiority Clinical Trials (2014) (0)
Abstract 11518: Diastolic Left Ventricular Dysfunction is a Common and Early Cardiac Abnormality in Hutchinson-Gilford Progeria Syndrome (2015) (0)
Abstract 5791: A New Score to Improve the Detection of Peripheral Artery Disease (2009) (0)
PITAVASTATIN REDUCES REMNANT LIPOPROTEIN CHOLESTEROL SIGNIFICANTLY MORE THAN DOES PRAVASTATIN IN HIV-INFECTED SUBJECTS: THE INTREPID TRIAL (2014) (0)
Matched Sampling for Causal Effects: Estimating and Using Propensity Scores with Partially Missing Data (2006) (0)
Algorithms for assessing cardiovascular risk in women. Authors' reply (2007) (0)
Abstract 16624: Lung Cancer Screening With CT, Coronary Artery Calcification and Cardiovascular Events (2015) (0)
99 Propensity score techniques for estimating treatment effects in clinical trials with drop-outs (1997) (0)
Abstract 13308: Prevalent Cardiovascular Disease and Progression of Carotid Intima-Media Thickness (2011) (0)
Estimating incidence of type 1 and type 2 diabetes using prevalence data: the SEARCH for Diabetes in Youth study (2023) (0)
3141Predicting life-expectancy without recurrent vascular events in patients with cardiovascular disease: the REACH-SMART model (2018) (0)
Is elevated blood pressure a hazard in the very old? Insights from the framingham study (1996) (0)
The Prevention and Treatment of Missing Data in Clinical Trials. Pannel on Handling Missing Data in Clinical Trials (2010) (0)
CONCENTRATIONS OF PRO-NEUROTENSIN, CARDIAC STRUCTURE, AND CORONARY ARTERY CALCIUM IN THE COMMUNITY: THE FRAMINGHAM HEART STUDY (2016) (0)
The impact of moderate elevations of blood pressure and low-density lipoprotein chlosterol on coronary heart disease risk (2003) (0)
SECULAR TRENDS IN STROKE INCIDENCE AND MORTALITY. RESPONSE (1993) (0)
Artery Calcium in the Framingham Heart Study (2020) (0)
Discussion of papers of session 2: Incomplete, multivariate, non‐linear (1992) (0)
Abstract 1139: Plasminogen Activator Inhibitor (PAI-1) and Risk of Cardiovascular Disease: The Framingham Heart Study (2009) (0)
Abstract 899: The Impact Of Attained Educational Level On Incident Cardiovascular Events Differs Between High-Income Countries and Low-and-Middle-Income Countries (2009) (0)
Comparison of Two Nutritional Risk Scores to Assess Overweight and Obesity Risk in Women: The Framingham Nutrition Studies (2008) (0)
P 0262 Risperidone and liver function tests in children and adolescents : A short term prospective study (0)
Abstract 4104: The Joint Impact of Visceral Adipose Tissue and Body Mass Index on Metabolic Risk Factors for Cardiovascular Disease: the Framingham Heart Study (2006) (0)
Abstract 15535: Protein Biomarkers of New-Onset Atherosclerotic Cardiovascular Disease (2013) (0)
2.W11.4 Comparison of risk factor levels in Framingham Cohort and Offspring participants (1997) (0)
Examining EMS:: A Consideration of Contemporary Topics (1983) (0)
An Addendum to “Linear Estimation of the Weibull Parameters” (1971) (0)
Abstract 13376: Lipid-Lowering Therapy Decreases Common Carotid Artery Intima-Media Thickness (IMT) Progression in Individuals Free of Prevalent Cardiovascular Disease: The Framingham Heart Study (2011) (0)
Obesity confers similar 30-year risk of cardiovascular disease or diabetes as hypertension or hypercholesterolemia in young adults (2013) (0)
Dietary Quality, Overweight, and Obesity in Women: The Framingham Nutrition Studies (2006) (0)
Abstract TP75: Creatinine on Admission Interacts with Intravenous Thrombolysis and Thrombectomy Procedures in Predicting Post-stroke Outcomes (2017) (0)
Abstract MP54: Dietary Protein Lowers Obesity Risk in Middle-Aged Framingham Offspring Study Adults (2015) (0)
Validation of a new predictive risk model for mortality using Framingham Heart Study data (2013) (0)
Abstract 5828: Carotid Artery Plaque is More Strongly Associated With Prior Cardiovascular Risk Factor Levels Than With Current Risk Factor Levels (2009) (0)
With the Chinese Multi-provincial Cohort Study Framingham CHD Risk Assessment Tool Compared Predictive Value for the Chinese Population of the (2008) (0)
Hypertension Associated and Risk of Risk Factors in Stroke : The Influence the Framingham Study of (2006) (0)
Abstract 17105: Lifecourse Analysis Reveals Adverse Cardiovascular Disease Risk Factor Profiles up to 30 Years Prior to the Diagnosis of Diabetes (2010) (0)
List of speakers and discussants (1992) (0)
Abstract 14203: Risk Factors for the Development of Carotid Artery Plaque: The Framingham Heart Study (2011) (0)
Abstract: 108 CVD GLOBAL RISK MODELS: THE FRAMINGHAM EXPERIENCE (2009) (0)
Abstract P065: Exposure to Traffic and Fine Particulate Matter and Aortic Calcium in the Framingham Offspring and Third Generation Cohorts (2016) (0)
Stroke, Obstructive Sleep Apnea, and Disorders of Glucose Metabolism—Reply (2006) (0)
Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV (2020) (0)
Vitamin D Deficiency and Risk of Cardiovascular Disease Epidemiology (2008) (0)
Abstract 15840: Clinical Predictors of Heart Failure with Preserved vs Reduced Ejection Fraction: Data from the Framingham Heart Study (2010) (0)
Updating our aims and scope for the future (2009) (0)
Relationship Between Blood ressure and C-Reactive Protein in the ulti-Ethnic Study of Atherosclerosis ( MESA ) (2016) (0)
Abstract 12115: The Impact of Maternal Dyslipidemia Prior to Pregnancy on Adult Offspring Lipid Levels (2013) (0)
Abstract 17169: Carotid Plaque Improves Discrimination and Reclassification of Cardiovascular Risk Prediction Models (2010) (0)
EVALUATION OF DRUGS TO TREAT CHILDREN WITH IBD (2012) (0)
IS THERE TENSION IN HYPERTENSION. AUTHOR'S REPLIES (1994) (0)
[The acute and 24-hour modifications to the atrial natriuretic factor in patients who have undergone mitral valvuloplasty. The hemodynamic and echocardiographic correlations]. (1993) (0)
Abstract 5153: Pericardial Fat, Intra-Thoracic Fat, and Left Ventricular Mass: The Framingham Heart Study (2008) (0)
Abstract: S5-1 STATISTICAL ISSUES IN RISK PREDICTION (2009) (0)
Introduction to Randomized Clinical Trials in Cardiovascular Disease (2012) (0)
Response to Letter Regarding Article, “Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries” (2011) (0)
ASSOCIATION BETWEEN PLASMAHOMOCYSTEINE, VITAMIN STATUS, ANDEXTRACRANIAL CAROTID-ARTERYSTENOSIS IN THE FRAMINGHAM STUDYPOPULATION (1997) (0)
Abstract 14701: Future Risk of Cardiovascular Disease in Adults with Prolonged Exposure to High Blood Pressure (2014) (0)
Emergency Medical Technician and Paramedic Training (1983) (0)
Abstract MP65: Clinical Correlation of Neck Circumference and Carotid-Wall Intima-Media Thickness (2013) (0)
Abstract P032: Increased Abdominal Aortic Diameters on Multidetector CT Scan Are Independent Predictors of Incident Adverse Cardiovascular Events: The Framingham Heart Study (2017) (0)
Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study (2015) (0)
Normality, Tests of (2005) (0)
Obesity and Offspring Serum Alanine and Aspartate minotransferase Levels : The Framingham Heart Study (2008) (0)
Mathematical Modeling: Applications in Emergency Health Services (1984) (0)
Variability and associations of fibrinogen and C-reactive protein in the Framingham offspring study (1998) (0)
Abstract 18240: The Diagnostic and Prognostic Utility of High Sensitivity Troponin I in Patients undergoing Diagnostic Angiography: Results From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study (2017) (0)
Prolonged PR interval is associated with increased risk of atrial fibrillation: the framingham heart study (2002) (0)
Cluster Analysis, Variables† (2014) (0)
Abstract 30, 10th International Workshop on HIV, Madrid, Spain (2006) (0)
Absence of Association Between Polymorphisms in the Hemostatic Factor Pathway Genes and Carotid Intimal Medial Thickness The Framingham Heart Study Research (2004) (0)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction Heart Failure (2008) (0)
Multiple Endpoints, P Level Procedures (2005) (0)
Abstract 874: Education Independently Predicts Risk of Cardiovascular Disease but Only Modestly Improves Performance of Framingham Risk Functions (2009) (0)
Abstract 1152: Diet Quality, Lifestyle and Weight Change in Framingham Women and Men: The Framingham Nutrition Studies (2009) (0)
An aid for diagnosing acute ischemic heart disease in the emergency room. (1984) (0)
Does Physical Activity Prevent Peripheral Vascular Disease?: The Framingham Experience (2000) (0)
Transient Ischemic Attack : The Framingham Study Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and (2001) (0)
Restructuring the editorial board (2005) (0)
Initial Stroke Subtype and Distribution of Cases With Silent Stroke Stroke subtype Atherosclerotic brain infarction Cerebral embolism Lacunar infarct Intracerebral hemorrhage Subarachnoid hemorrhage Total No (2005) (0)
Cardiovascular disease prevention VII London, UK (2005) (0)
Diet Quality and Development of Abdominal Obesity in Women: Comparison of Two Composite Nutritional Risk Scores. The Framingham Nutrition Studies (2008) (0)
014 Risk score to predict serious bleeding in stable outpatients with atherothrombosis (2010) (0)
Editorial Commentary: There's No Time Like the Present if You Want to Save Your Mechanoreceptors! (2016) (0)
Response to the Letter by Masuo R., et al. (2015) (0)
Normality Tests: Overview (2014) (0)
JobStrain andHealth-Related Quality ofLife inaNational Sample (1994) (0)
Biosimilars for Drug Development: The Time Is Now! (2016) (0)
Impact of Maternal Pre-Pregnancy Dyslipidemia Exposure on Adult Offspring Lipid Levels (2013) (0)
Abstract 3647: Dietary Patterns and Risk of Increased Carotid Intima-Media Thickness in Women: The Framingham Nutrition Studies (2007) (0)
Beginning the next 25 years (2007) (0)
Understanding increments in model performance metrics (2012) (0)
Primary prevention of cardiovascular disease (2006) (0)
Hemostatic predictors of cardiovascular disease: prospective evaluation of the framingham offspring study (2002) (0)
Abstract 3122: Differences in Intima Media Thickness of the Common and Internal Carotid Arteries (2008) (0)
Response to Letter Regarding Article, “Use of Alternative Thresholds Defining Insulin Resistance to Predict Incident Type 2 Diabetes Mellitus and Cardiovascular Disease” (2008) (0)
ACCURACY OF RAPID CARDIOVASCULAR MAGNETIC RESONANCE ASSESSMENT OF LEFT VENTRICULAR FUNCTION (2022) (0)
Comparison of a Historical Food Frequency Questionnaire with a Three-Day Diet Record (2010) (0)
Average Inferiority Measure and Standardized Margins to Address the Issues in Biosimilar Trials (2016) (0)
Platelet Glycoprotein IIIa Pl A Polymorphism, Fibrinogen, and Platelet Aggregability The Framingham Heart Study Clinical Investigation and Reports (2001) (0)
Abstract 16324: Framingham Offspring Cohort Genome-Wide Association Study of Gamma' Fibrinogen Levels (2011) (0)
Have lower efficacy but similar effectiveness to inhaled corticosteroids (2016) (0)
TCT-212 Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies (2017) (0)
Equivalence and non inferiority trials (2011) (0)
D-Dimer and the Risk of Cardiovascular Disease: The Framingham Heart Study (2011) (0)
Abstract 1191: Trends in Cardiovascular Disease Risk Factors among Middle-Aged Individuals with and without Diabetes in the Framingham Heart Study (2008) (0)
Correction:Methods for Voluntary Weight Loss and Control (1993) (0)
Letters to the Editor Simultaneous Bihemispherical Assessment of Cerebral Blood Flow Velocity Changes During a Mental Arithmetic Task (2008) (0)
Coronary Heart Disease Impact of Impaired Fasting Glucose on Cardiovascular Disease The Framingham Heart Study (2008) (0)
Is There Tension in Hypertension?-Reply (1994) (0)
Evidence on the Validity of a Comprehensive Health Risk Index and Implications for Ambulatory Care and Population Health Management (2017) (0)

This paper list is powered by the following services:

Ralph B. Sr. D’agostino's Academic­Influence.com Rankings

Why Is Ralph B. Sr. D’agostino Influential?

Ralph B. Sr. D’agostino's Published Works

Published Works

Ralph B. Sr. D’agostino's AcademicInfluence.com Rankings